This federal contract award, identified as SPE2DB22D3501 and SPE2DB23FVP94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $2,097.07 and is set to expire on May 9, 2023, is for the delivery of NEXTERONE 360 MG/200 ML BAG 200ML, a medical product.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
This specific contract award was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is the prime contractor, and no major subcontractors are mentioned. The Defense Logistics Agency, a defense agency responsible for managing the supply chain and providing logistics support to the U.S. military and other federal agencies, is the funding agency for this contract.